Engineering the Direct Repeat Sequence of crRNA for Optimization of FnCpf1-Mediated Genome Editing in Human Cells.

FnCpf1-mediated genome-editing technologies have enabled a broad range of research and medical applications. Recently, we reported that FnCpf1 possesses activity in human cells and recognizes a more compatible PAM (protospacer adjacent motif, 5'-KYTV-3'), compared with the other two commonly used Cpf1 enzymes (AsCpf1 and LbCpf1), which requires a 5'-TTTN-3' PAM. However, due to the efficiency and fidelity, FnCpf1-based clinical and basic applications remain a challenge. The direct repeat (DR) sequence is one of the key elements for FnCpf1-mediated genome editing. In principle, its engineering should influence the corresponding genome-editing activity and fidelity. Here we showed that the DR mutants [G(-9)A and U(-7)A] could modulate FnCpf1 performance in human cells, enabling enhancement of both genome-editing efficiency and fidelity. These newly identified features will facilitate the design and optimization of CRISPR-Cpf1-based genome-editing strategies.

[1]  Daniel G. Anderson,et al.  Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing , 2017, Nature Biotechnology.

[2]  Jin-Soo Kim,et al.  Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells , 2016, Nature Biotechnology.

[3]  A. Regev,et al.  Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System , 2015, Cell.

[4]  Feng Zhang,et al.  Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA , 2014, Cell.

[5]  Jin-Soo Kim,et al.  Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins , 2016, Nature Biotechnology.

[6]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[7]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[8]  Jennie Choi,et al.  Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency , 2015, Genome Biology.

[9]  Feng Gu,et al.  Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells , 2014, Scientific Reports.

[10]  E. Olson,et al.  Publication : CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice , 2018 .

[11]  Feng Zhang,et al.  Engineered Cpf1 variants with altered PAM specificities increase genome targeting range , 2017, Nature Biotechnology.

[12]  Peter C. Fineran,et al.  The Cpf1 CRISPR-Cas protein expands genome-editing tools , 2015, Genome Biology.

[13]  Ryan D. Chow,et al.  Programmable sequential mutagenesis by inducible Cpf1 crRNA array inversion , 2018, Nature Communications.

[14]  Israel Steinfeld,et al.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells , 2015, Nature Biotechnology.

[15]  Yongsub Kim,et al.  Generation of knockout mice by Cpf1-mediated gene targeting , 2016, Nature Biotechnology.

[16]  Kira S. Makarova,et al.  Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA , 2016, Cell.

[17]  Kira S. Makarova,et al.  SnapShot: Class 2 CRISPR-Cas Systems , 2017, Cell.

[18]  Junhao Fu,et al.  A ‘new lease of life’: FnCpf1 possesses DNA cleavage activity for genome editing in human cells , 2017, Nucleic acids research.

[19]  Feng Gu,et al.  SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells. , 2018, Biotechnology journal.

[20]  J. Joung,et al.  High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets , 2015, Nature.

[21]  Martin J. Aryee,et al.  Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells , 2016, Nature Biotechnology.

[22]  Ningning Li,et al.  The crystal structure of Cpf1 in complex with CRISPR RNA , 2016, Nature.

[23]  Feng Gu,et al.  A Single Multiplex crRNA Array for FnCpf1-Mediated Human Genome Editing. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  David R. Liu,et al.  CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes , 2017, Cell.

[25]  D. Patel,et al.  Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition , 2016, Cell Research.

[26]  D. C. Swarts,et al.  Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a. , 2017, Molecular cell.

[27]  Graham Dellaire,et al.  Marker-free coselection for CRISPR-driven genome editing in human cells , 2017, Nature Methods.

[28]  Jie Zhang,et al.  Multiplexed CRISPR-Cpf1-Mediated Genome Editing in Clostridium difficile toward the Understanding of Pathogenesis of C. difficile Infection. , 2018, ACS synthetic biology.